Par Drugs and Chemicals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 244.92 million compared to INR 220.81 million a year ago. Revenue was INR 245.23 million compared to INR 221.48 million a year ago. Net income was INR 34.47 million compared to INR 24.22 million a year ago. Basic earnings per share from continuing operations was INR 2.8 compared to INR 1.97 a year ago. Diluted earnings per share from continuing operations was INR 2.8 compared to INR 1.97 a year ago.
For the full year, sales was INR 957.49 million compared to INR 750.74 million a year ago. Revenue was INR 959.87 million compared to INR 752.58 million a year ago. Net income was INR 113.34 million compared to INR 92.13 million a year ago. Basic earnings per share from continuing operations was INR 9.21 compared to INR 7.49 a year ago. Diluted earnings per share from continuing operations was INR 9.21 compared to INR 7.49 a year ago.